[8]
Daiichi is also the owner of Canadian Patent 1,157,840 ('840 patent), issued on May 22, 1984, which disclosed and claimed an antibiotic known as "ofloxacin". Janssen was licensed by Daiichi to market ofloxacin in Canada, which it did under the brand name FLOXIN. The '840 ofloxacin patent expired on May 22, 2001.